Edwards Lifesciences (EW) PT Raised to $250 at RBC Capital Into Q3
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- S&P 500 futures steady after midterm rally; Nasdaq lags on chip weakness
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Edwards Lifesciences (NYSE: EW) | Delayed: 99.37 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $99.37 | 52 Week High | $166.87 | |||
| Open | $99.37 | 52 Week Low | $72.20 | |||
| Day High | $99.37 | P/E | 28.89 | |||
| Day Low | $99.37 | EPS | $3.44 | |||
| Volume | 6,393 | |||||
